DDL
Iconovo is proud to sponsor DDL this year again. We see DDL as the most important meeting for inhaled drug delivery in Europe and we are looking forward…
Iconovo has a new granted patent
The Swedish Patent and Registration Office, PRV, has granted Iconovo's first ICOone patent. This is a key milestone showing that Iconovo's inhalers are…
New employees at Iconovo
We welcome our two new associates; Maggie Adméus and Henrik Svedberg. Maggie as an Executive Assistant and Henrik as a Mechanical Engineer.
New employee at Iconovo
Mårten Appelgren has joined Iconovo as Director Business Development. Mårten has over 25 years experience from the inhalation industry. Mårten has previously…
New employee at Iconovo
We are very glad to announce that Vesna Åkerberg has joined Iconovo as Director of Pharmaceutical Development. Vesna will head the new dry powder formulation…
New Labs and offices at Medicon Village
Iconovo has moved into new labs and offices at Medicon Village. We have now doubled our space and have several specialized labs and equipment for dry powder…
Investment in formulation development
Iconovo has raised 2.3 million EUR to expand the in-house development capacity. We will now be able to offer a comprehensive product development including…
Dry Powder Inhalers in London
Iconovo CEO Dr. Orest Lastow will be giving a speach at Dry Powder Inhalers Conference 27-28 July in London. The title of the speach is "How to develop…
Iconovo at RDD in Nice
Iconovo will be joining RDD Europe 2017 in Nice next week. Iconovo's participation was made possible by the kind support from the EU financed SSGG …
New employees at Iconovo
We welcome our two new associates: Richard Johnson and Fredrik Gunnarsson. Richard is a Mechanical Engineer and Fredrik is an Analytical Chemist.